BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9917559)

  • 1. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
    Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
    Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
    Santucci R; Levêque D; Kemmel V; Lutz P; Gérout AC; N'guyen A; Lescoute A; Schneider F; Bergerat JP; Herbrecht R
    Anticancer Res; 2010 Mar; 30(3):963-5. PubMed ID: 20393020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW; Al Omar S
    J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
    Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
    Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
    Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
    Al-Turkmani MR; Law T; Narla A; Kellogg MD
    Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary.
    Milone MC
    Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure.
    Zoubek A; Zaunschirm HA; Lion T; Fischmeister G; Vollnhofer G; Gadner H; Pillwein K; Schalhorn A; Bode U
    Pediatr Hematol Oncol; 1995; 12(5):471-7. PubMed ID: 8519632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary.
    Fox E; Balis FM
    Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose carboxypeptidase-G2 for methotrexate toxicity in a child.
    Qudsi R; Abdulhadi O; Sultan I
    Pediatr Blood Cancer; 2010 Dec; 55(7):1439-40. PubMed ID: 20981700
    [No Abstract]   [Full Text] [Related]  

  • 17. "Rescue" agent may circumvent rare but deadly complication from chemotherapy.
    Jenks S
    J Natl Cancer Inst; 1997 Jun; 89(12):840-1. PubMed ID: 9196247
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
    Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
    Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate nephrotoxicity: Novel treatment, new approach.
    Iqbal S; Armaghani A; Aiyer R; Kazory A
    J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate poisoning with acute hepatorenal dysfunction.
    Goto E; Tomojiri S; Okamoto I; Tanaka K
    J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.